(LIN) Linde Ordinary Shares - Overview
Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NASDAQ (USA) | Market Cap: 230.106m USD | Total Return: 9% in 12m
Avg Turnover: 1.05B
EPS Trend: 99.1%
Qual. Beats: 4
Rev. Trend: 81.2%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Shakeout, Confidence
Linde plc is a global leader in the industrial gases sector, producing and distributing atmospheric gases such as oxygen and nitrogen alongside specialty process gases like hydrogen and helium. The company operates a dual-business model that combines gas supply with a proprietary engineering division focused on designing and constructing large-scale chemical and gas processing plants. This integrated approach allows Linde to serve diverse end-markets, including healthcare, electronics, and energy production, across major economies in the Americas, Europe, and Asia-Pacific.
The industrial gas industry is characterized by high barriers to entry due to the capital-intensive nature of air separation units and the logistical complexity of gas distribution. Linde typically utilizes long-term, take-or-pay contracts for on-site supply, which provides a high degree of revenue stability and integrates the company directly into the supply chains of its industrial customers. For a deeper look at company valuation metrics, consider reviewing the latest data on ValueRay.
- Expansion of global clean hydrogen infrastructure drives long-term capital expenditure growth
- Resilience in long-term take-or-pay contracts stabilizes cash flow during macro volatility
- Semiconductor manufacturing expansion in Asia and US boosts high-margin electronic gas demand
- Energy price fluctuations impact production costs and industrial customer manufacturing output
- Strategic pricing power in global industrial gas markets offsets persistent inflationary pressures
| Net Income: 7.12b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.03 > 1.0 |
| NWC/Revenue: -7.62% < 20% (prev -2.69%; Δ -4.93% < -1%) |
| CFO/TA 0.12 > 3% & CFO 10.4b > Net Income 7.12b |
| Net Debt (21.8b) to EBITDA (13.8b): 1.58 < 3 |
| Current Ratio: 0.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (466.3m) vs 12m ago -2.09% < -2% |
| Gross Margin: 45.99% > 18% (prev 36.93%; Δ 9.07% > 0.5%) |
| Asset Turnover: 41.01% > 50% (prev 39.92%; Δ 1.09% > 0%) |
| Interest Coverage Ratio: 36.42 > 6 (EBIT TTM 9.98b / Interest Expense TTM 274.0m) |
| A: -0.03 (Total Current Assets 12.8b - Total Current Liabilities 15.4b) / Total Assets 86.3b |
| B: 0.20 (Retained Earnings 17.6b / Total Assets 86.3b) |
| C: 0.12 (EBIT TTM 9.98b / Avg Total Assets 84.5b) |
| D: 0.83 (Book Value of Equity 38.6b / Total Liabilities 46.2b) |
| Altman-Z'' = 2.14 = BBB |
| DSRI: 1.03 (Receivables 5.64b/5.24b, Revenue 34.7b/33.0b) |
| GMI: 0.80 (GM 36.93% / 45.99%) |
| AQI: 0.99 (AQ_t 0.52 / AQ_t-1 0.52) |
| SGI: 1.05 (Revenue 34.7b / 33.0b) |
| TATA: -0.04 (NI 7.12b - CFO 10.4b) / TA 86.3b) |
| Beneish M = -3.16 (Cap -4..+1) = AA |
As of June 04, 2026, the stock is trading at USD 507.57 with a total of 2,257,059 shares traded.
Over the past week, the price has changed by -0.06%,
over one month by +2.84%,
over three months by +1.51% and
over the past year by +9.03%.
Linde Ordinary Shares has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy LIN.
- StrongBuy: 12
- Buy: 6
- Hold: 9
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 541.6 | 6.7% |
P/E Trailing = 33.0033
P/E Forward = 28.4091
P/S = 6.6971
P/B = 6.0886
P/EG = 2.3644
Revenue TTM = 34.7b USD
EBIT TTM = 9.98b USD
EBITDA TTM = 13.8b USD
Long Term Debt = 19.9b USD (from longTermDebt, last quarter)
Short Term Debt = 4.82b USD (from shortTermDebt, last quarter)
Debt = 25.8b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.08b
Net Debt = 21.8b USD (calculated: Debt 25.8b - CCE 3.96b)
Enterprise Value = 252b USD (230b + Debt 25.8b - CCE 3.96b)
Interest Coverage Ratio = 36.42 (Ebit TTM 9.98b / Interest Expense TTM 274.0m)
EV/FCF = 49.43x (Enterprise Value 252b / FCF TTM 5.10b)
FCF Yield = 2.02% (FCF TTM 5.10b / Enterprise Value 252b)
FCF Margin = 14.70% (FCF TTM 5.10b / Revenue TTM 34.7b)
Net Margin = 20.56% (Net Income TTM 7.12b / Revenue TTM 34.7b)
Gross Margin = 45.99% ((Revenue TTM 34.7b - Cost of Revenue TTM 18.7b) / Revenue TTM)
Gross Margin QoQ = 48.49% (prev 48.12%)
Tobins Q-Ratio = 2.92 (Enterprise Value 252b / Total Assets 86.3b)
Interest Expense / Debt = 1.06% (Interest Expense 274.0m / Debt 25.8b)
Taxrate = 21.95% (2.02b / 9.18b)
NOPAT = 7.79b (EBIT 9.98b * (1 - 21.95%))
Current Ratio = 0.83 (Total Current Assets 12.8b / Total Current Liabilities 15.4b)
Debt / Equity = 0.67 (Debt 25.8b / totalStockholderEquity, last quarter 38.6b)
Debt / EBITDA = 1.58 (Net Debt 21.8b / EBITDA 13.8b)
Debt / FCF = 4.28 (Net Debt 21.8b / FCF TTM 5.10b)
Total Stockholder Equity = 38.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.43% (Net Income 7.12b / Total Assets 86.3b)
RoE = 18.51% (Net Income TTM 7.12b / Total Stockholder Equity 38.5b)
RoCE = 17.10% (EBIT 9.98b / Capital Employed (Equity 38.5b + L.T.Debt 19.9b))
RoIC = 10.52% (NOPAT 7.79b / Invested Capital 74.0b)
WACC = 6.40% (E(230b)/V(256b) * Re(7.02%) + D(25.8b)/V(256b) * Rd(1.06%) * (1-Tc(0.22)))
Discount Rate = 7.02% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.56 | Cagr: -2.38%
[DCF] Terminal Value 75.93% ; FCFF base≈5.02b ; Y1≈5.20b ; Y5≈5.86b
[DCF] Fair Price = 148.7 (EV 90.5b - Net Debt 21.8b = Equity 68.7b / Shares 462.3m; r=8.35% [WACC [floored]]; 5y FCF grow 3.77% → 2.50% )
EPS Correlation: 99.05 | EPS CAGR: 8.47% | SUE: 3.01 | # QB: 4
Revenue Correlation: 81.18 | Revenue CAGR: 1.62% | SUE: 1.18 | # QB: 1
EPS current Quarter (2026-06-30): EPS=4.39 | Chg30d=N/A | Revisions=+62% | Analysts=18
EPS next Quarter (2026-09-30): EPS=4.61 | Chg30d=N/A | Revisions=-5% | Analysts=17
EPS current Year (2026-12-31): EPS=17.95 | Chg30d=N/A | Revisions=+69% | GrowthEPS=+9.0% | GrowthRev=+7.7%
EPS next Year (2027-12-31): EPS=19.71 | Chg30d=N/A | Revisions=+64% | GrowthEPS=+9.8% | GrowthRev=+4.6%
[Analyst] Revisions Ratio: +69%